Reichman, Bonnie S

Publications

Sort by

Co-Author Network

selected publications

Isolated sternal involvement in breast cancer: is it truly stage IV disease?. Clinical breast cancer. 2011 Academic Article GET IT
Times cited: 2
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 49
Fertility and pregnancy after adjuvant chemotherapy for breast cancer. Critical reviews in oncology/hematology. 1998 Information Resource GET IT
Times cited: 27
High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up. Gynecologic oncology. 1997 Academic Article GET IT
Times cited: 25
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 217
Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer. Oncology. 1994 Academic Article GET IT
Times cited: 3
Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 1994 Academic Article GET IT
Times cited: 15
Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer. Gynecologic oncology. 1993 Academic Article GET IT
Mitomycin-C plus a 3-day continuous intravenous infusion of 5-fluorouracil: an inactive salvage regimen for platinum-resistant ovarian carcinoma. Gynecologic oncology. 1993 Academic Article GET IT
Impact of age on survival of patients with ovarian cancer. Gynecologic oncology. 1993 Academic Article GET IT
Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: influence of increasing the volume of treatment. Gynecologic oncology. 1993 Academic Article GET IT
The use of recombinant human erythropoietin to prevent carboplatin-induced anemia. Gynecologic oncology. 1993 Academic Article GET IT
Phase II trial of carboplatin and etoposide in metastatic breast cancer. Cancer. 1993 Academic Article GET IT
Times cited: 14
Evidence for persistence of mitoxantrone within the peritoneal cavity following intraperitoneal delivery. Gynecologic oncology. 1993 Academic Article GET IT
Times cited: 11
Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience. Cancer. 1993 Academic Article GET IT
Times cited: 72
Diethyldithiocarbamate chemoprotection of carboplatin--induced hematological toxicity. Journal of cancer research and clinical oncology. 1993 Academic Article GET IT
Times cited: 12
Intraperitoneal administration of Taxol in the management of ovarian cancer. Journal of the National Cancer Institute. Monographs. 1993 Information Resource GET IT
Times cited: 8
Phase II trial of zeniplatin (CL 286,558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy. Journal of cancer research and clinical oncology. 1993 Academic Article GET IT
Times cited: 6
Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells. Journal of the National Cancer Institute. 1992 Article GET IT
Times cited: 34
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?. Seminars in oncology. 1992 Academic Article GET IT
Times cited: 6
Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer. Gynecologic oncology. 1992 Academic Article GET IT
Times cited: 16
Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 80
Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 288
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 183
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 151
Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy. Journal of cancer research and clinical oncology. 1992 Academic Article GET IT
Times cited: 2
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 227
Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy. Journal of cancer research and clinical oncology. 1992 Academic Article GET IT
Times cited: 13
Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer. Journal of cancer research and clinical oncology. 1992 Academic Article GET IT
Times cited: 56
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rate. Journal of cancer research and clinical oncology. 1992 Academic Article GET IT
Times cited: 5
Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapy. Gynecologic oncology. 1991 Academic Article GET IT
Times cited: 10
Extrahepatic biliary system cancer: an update of a combined modality approach. American journal of clinical oncology. 1991 Academic Article GET IT
Times cited: 35
Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 185
Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube. Gynecologic oncology. 1991 Academic Article GET IT
Times cited: 50
Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecologic oncology. 1991 Academic Article GET IT
Times cited: 111
Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinoma. Gynecologic oncology. 1991 Academic Article GET IT
Times cited: 6
Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 41
Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer. 1991 Academic Article GET IT
Times cited: 82
Intraperitoneal chemotherapy: analysis of complications with an implanted subcutaneous port and catheter system. Gynecologic oncology. 1991 Academic Article GET IT
Times cited: 64
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 723
Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 46
Chemotherapy-induced neutropenia and fever in patients receiving cisplatin-based chemotherapy for ovarian malignancy. Gynecologic oncology. 1991 Academic Article GET IT
Times cited: 16
Haemodynamic effects of recombinant interleukin-2 administered by constant infusion. European journal of cancer. 1991 Academic Article GET IT
Times cited: 2
Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancer. Journal of cancer research and clinical oncology. 1991 Academic Article GET IT
Times cited: 27
Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate. Journal of cancer research and clinical oncology. 1991 Academic Article GET IT
Times cited: 34
Aggressive chemosurgical debulking in patients with advanced ovarian cancer. Gynecologic oncology. 1990 Academic Article GET IT
Times cited: 38
Combined modality therapy of extrahepatic biliary system cancer. International journal of radiation oncology, biology, physics. 1990 Academic Article GET IT
Times cited: 42
Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1990 Academic Article GET IT
Times cited: 76
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma. Gynecologic oncology. 1989 Academic Article GET IT
Times cited: 124
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1989 Academic Article GET IT
Times cited: 86
Cisplatin and 5-fluorouracil infusion for metastatic colorectal carcinoma. Differences in survival in two patient groups with similar response rates. Cancer. 1989 Academic Article GET IT
Times cited: 14
Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience). Acta medica Austriaca. 1989 Academic Article GET IT
Times cited: 5
Implementation of the group sequential methodology in a randomized trial in metastatic colorectal carcinoma. American journal of clinical oncology. 1988 Academic Article GET IT
Times cited: 12
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988 Academic Article GET IT
Times cited: 6
Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Annals of internal medicine. 1987 Academic Article GET IT
Times cited: 584
Phase II trial of ifosfamide and mesna in advanced colorectal cancer. Cancer treatment reports. 1987 Academic Article GET IT
Times cited: 5

more ...

less ...

Background

education and training

M.D., St. Louis University School of Medicine 1980
B.A., Cornell University 1976

Contact

full name

Bonnie S Reichman

primary email

bsr2001@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Bonnie S Reichman Clinical Associate Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage